FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Klaus Wolff

Research Profile

Disorders

Living Beings

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Sonja Hirschl; Oliver Schanab; Heide Seppele; Andrea Waltenberger; Johannes Humer; Klaus Wolff; Hubert Pehamberger; Thomas Muster
Sequence variability of retroviral particles derived from human melanoma cells melanoma-associated retrovirus.
Markus Dawid; Marge Veensalu; Maximilian Grassberger; Klaus Wolff
Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study.
Klaus Wolff
Irwin Freedberg, editor extraordinaire of Fitzpatrick's DIGM.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Klaus Wolff (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Sonja Hirschl; Oliver Schanab; Heide Seppele; Andrea Waltenberger; Johannes Humer; Klaus Wolff; Hubert Pehamberger; Thomas Muster
Sequence variability of retroviral particles derived from human melanoma cells melanoma-associated retrovirus.
Virus research 2007;123(2):211-5.
2006: Markus Dawid; Marge Veensalu; Maximilian Grassberger; Klaus Wolff
Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2006;4(11):942-6.
2006: Klaus Wolff
Irwin Freedberg, editor extraordinaire of Fitzpatrick's DIGM.
The Journal of investigative dermatology 2006;126(3):524-5.
2006: Johannes Humer; Andrea Waltenberger; Andreas Grassauer; Martin Kurz; Julia Valencak; Ronald Rapberger; Silvia Hahn; Roswitha Löwer; Klaus Wolff; Michael Bergmann; Thomas Muster; Bernd Mayer; Hubert Pehamberger
Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses.
Cancer research 2006;66(3):1658-63.
2005: Gabriele Hinterhuber; Karla Cauza; Ruth Dingelmaier-Hovorka; Elisabeth Diem; Reinhard Horvat; Klaus Wolff; Dagmar Foedinger
Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
The British journal of dermatology 2005;153(4):785-9.
2005: Elisabeth Heere-Ress; Johannes Boehm; Christiane Thallinger; Christoph Hoeller; Volker Wacheck; Peter Birner; Klaus Wolff; Hubert Pehamberger; Burkhard Jansen
Thalidomide enhances the anti-tumor activity of standard chemotherapy in a human melanoma xenotransplatation model.
The Journal of investigative dermatology 2005;125(2):201-6.
2005: Gabriele Hinterhuber; Michael Binder; Y Marquardt; Karla Cauza; Elisabeth Riedl; Klemens Rappersberger; Klaus Wolff; Dagmar Foedinger
Enzyme-linked immunosorbent assay for detection of peptide-specific human antidesmoplakin autoantibodies.
The British journal of dermatology 2005;153(2):413-6.
2005: Klaus Wolff; C Fleming; Jon M Hanifin; Kim A Papp; Sakari Reitamo; M Rustin; N Shear; W Silny; N Korman; I Marks; Robert Cherill; S Emady-Azar; Carle Paul
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial.
The British journal of dermatology 2005;152(6):1296-303.
2005: Christine Hafner; Heimo Breiteneder; Soldano Ferrone; Christiane Thallinger; Stefan Wagner; Wolfgang M Schmidt; Joanna Jasinska; Michael Kundi; Klaus Wolff; Christoph C Zielinski; Otto Scheiner; Ursula Wiedermann; Hubert Pehamberger
Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
International journal of cancer. Journal international du cancer 2005;114(3):426-32.
2005: Ichiro Okamoto; Christine Pirker; Martin Bilban; Walter Berger; Doris Losert; Christine Marosi; Oskar A Haas; Klaus Wolff; Hubert Pehamberger
Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma.
Neoplasia (New York, N.Y.) 2005;7(4):303-11.
2005: peter petzelbauer; Paula A Zacharowski; Yasuhiro Miyazaki; Peter Friedl; Georg Wickenhauser; Francis J Castellino; Marion Gröger; Klaus Wolff; Kai Zacharowski
The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury.
Nature medicine 2005;11(3):298-304.
2005: Florian Roka; Harald Kittler; P Cauzig; Christoph Hoeller; Gabriele Hinterhuber; Klaus Wolff; Hubert Pehamberger; Elisabeth Diem
Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
British journal of cancer 2005;92(4):662-7.
2005: Karla Cauza; Gabriele Hinterhuber; Ruth Dingelmaier-Hovorka; Karin Brugger; Gabriele Klosner; Reinhard Horvat; Klaus Wolff; Dagmar Foedinger
Expression of FcRn, the MHC class I-related receptor for IgG, in human keratinocytes.
The Journal of investigative dermatology 2005;124(1):132-9.
2005: Christine Hafner; Stefan Wagner; Joanna Jasinska; Dorothee Allwardt; Otto Scheiner; Klaus Wolff; Hubert Pehamberger; Ursula Wiedermann; Heimo Breiteneder
Epitope-specific antibody response to Mel-CAM induced by mimotope immunization.
The Journal of investigative dermatology 2005;124(1):125-31.
2004: Marion Gröger; Robert Loewe; Wolfgang Holnthoner; Robert Embacher; Manuela Pillinger; G Scott Herron; Klaus Wolff; peter petzelbauer
IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(12):7161-9.
2004: Peter Valent; Michel AROCK; Stephan C Bischoff; Hans-Jörg Bühring; Knut Brockow; Luis Escribano; Manuela Födinger; Jürgen Grabbe; Karin Hartmann; Beate M Henz; Hans-Peter Horny; Hanneke C Kluin-Nelemans; Margarida Lima; Gianni Marone; Alberto Orfao; Reza Parwaresch; Christian Sillaber; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Jasper J van Doormaal; Klaus Wolff; Torsten Zuberbier
The European Competence Network on Mastocytosis (ECNM).
Wiener klinische Wochenschrift 2004;116(19-20):647-51.
2004: Klaus Wolff
Current concepts and review of pimecrolimus in the treatment of psoriasis.
Dermatologic clinics 2004;22(4):461-5, ix-x.
2004: Robert Loewe; Harald Kittler; Gottfried Fischer; Ingrid Faé; Klaus Wolff; peter petzelbauer
BRAF kinase gene V599E mutation in growing melanocytic lesions.
The Journal of investigative dermatology 2004;123(4):733-6.
2004: Clemens Krepler; Ulrich Certa; Volker Wacheck; Burkhard Jansen; Klaus Wolff; Hubert Pehamberger
Pegylated and conventional interferon-alpha induce comparable transcriptional responses and inhibition of tumor growth in a human melanoma SCID mouse xenotransplantation model.
The Journal of investigative dermatology 2004;123(4):664-9.
2004: Karla Cauza; Gabriele Hinterhuber; Barbara Sterniczky; Karin Brugger; Friederike Pieczkowski; Franz Karlhofer; Klaus Wolff; Dagmar Foedinger
Unusual clinical manifestation of linear IgA dermatosis: a report of two cases.
Journal of the American Academy of Dermatology 2004;51(2 Suppl):S112-7.
2004: Erika Richtig; Rainer Hofmann-Wellenhof; Hubert Pehamberger; Ch Forstinger; Klaus Wolff; Paul Mischer; J Raml; Peter Fritsch; Bernhard Zelger; G Ratzinger; J Koller; A Lang; K Konrad; E Kindermann-Glebowski; A Seeber; Andreas Steiner; R Fialla; Wolf Pachinger; C Kos; G Klein; H Kehrer; Helmut Kerl; H Ulmer; Josef Smolle
Temozolomide and interferon alpha 2b in metastatic melanoma stage IV.
The British journal of dermatology 2004;151(1):91-8.
2004: Thomas Muster; Julia Rajtarova; Monika Sachet; Hermann Unger; Reinhard Fleischhacker; Ingrid Romirer; Andreas Grassauer; Angelika Url; Adolfo García-Sastre; Klaus Wolff; Hubert Pehamberger; Michael Bergmann
Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants.
International journal of cancer. Journal international du cancer 2004;110(1):15-21.
2004: Klaus Wolff; Anton Stuetz
Pimecrolimus for the treatment of inflammatory skin disease.
Expert opinion on pharmacotherapy 2004;5(3):643-55.
2004: Klaus Wolff
PUVA and the international nature of Dr Fitzpatrick's influence.
The Journal of investigative dermatology 2004;122(2):xviii-xix.
2004: Gabriele Hinterhuber; Karla Cauza; Karin Brugger; Ruth Dingelmaier-Hovorka; Reinhard Horvat; Klaus Wolff; Dagmar Foedinger
RPE65 of retinal pigment epithelium, a putative receptor molecule for plasma retinol-binding protein, is expressed in human keratinocytes.
The Journal of investigative dermatology 2004;122(2):406-13.
2004: Clemens Krepler; Volker Wacheck; Sabine Strommer; Gunther Hartmann; Peter Polterauer; Klaus Wolff; Hubert Pehamberger; Burkhard Jansen
CpG oligonucleotides elicit antitumor responses in a human melanoma NOD/SCID xenotransplantation model.
The Journal of investigative dermatology 2004;122(2):387-91.
2003: Thomas Muster; Andrea Waltenberger; Andreas Grassauer; Sonja Hirschl; Peri Caucig; Ingrid Romirer; Dagmar Födinger; Heide Seppele; Oliver Schanab; Christine Magin-Lachmann; Roswitha Löwer; Burkhard Jansen; Hubert Pehamberger; Klaus Wolff
An endogenous retrovirus derived from human melanoma cells.
Cancer research 2003;63(24):8735-41.
2003: Susana Ortiz-Urda; Adelheid Elbe-Bürger; Josef Smolle; Yvonne Marquart; Yakov Chudnovsky; todd ridky; Pamela Bernstein; Klaus Wolff; Klemens Rappersberger
The plant lectin wheat germ agglutinin inhibits the binding of pemphigus foliaceus autoantibodies to desmoglein 1 in a majority of patients and prevents pathomechanisms of pemphigus foliaceus in vitro and in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(11):6244-50.
2003: Harald Teufelsbauer; Alexander M Prusa; Klaus Wolff; Marjana Sahal; Peter Polterauer; Johannes Lammer; Thomas Hölzenbein; Georg Kretschmer; Ihor Huk
The impact of endovascular stent grafting on reducing mortality rates after surgical treatment of abdominal aortic aneurysms.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2003;26(5):494-500.
2003: Karla Cauza; Gabriele Hinterhuber; Ulrike Mann; Reinhard Horvat; Klemens Rappersberger; Klaus Wolff; Dagmar Foedinger
Internalization via plasmalemmal vesicles: a route for antidesmoplakin autoantibodies into cultured human keratinocytes.
Experimental dermatology 2003;12(5):546-54.
2003: Alexandra Harbauer; Michael Binder; Hubert Pehamberger; Klaus Wolff; Harald Kittler
Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk.
Melanoma research 2003;13(5):537-42.
2003: Harald Teufelsbauer; Alexander M Prusa; Klaus Wolff; Marjana Sahal; Thomas Hölzenbein; Georg Kretschmer; Ihor Huk; Peter Polterauer
[Ruptured abdominal aortic aneurysms: status quo after a quarter century of treatment experience].
Wiener klinische Wochenschrift 2003;115(15-16):584-9.
2003: Gabriele Hinterhuber; Johannes Drach; Elisabeth Riedl; Kornelia Böhler; Peter Ferenci; Klaus Wolff; Dagmar Foedinger
Paraneoplastic pemphigus in association with hepatocellular carcinoma.
Journal of the American Academy of Dermatology 2003;49(3):538-40.
2003: Christiane Thallinger; Markus F Wolschek; Volker Wacheck; Helmut Maierhofer; Patrick Günsberg; Peter Polterauer; Hubert Pehamberger; Brett P Monia; Edgar Selzer; Klaus Wolff; Burkhard Jansen
Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.
The Journal of investigative dermatology 2003;120(6):1081-6.
2003: Klaus Wolff
Quo vadis dermatology: a scenario for the future.
Journal of the American Academy of Dermatology 2003;48(4):605-8.
2003: Barbara Rosado; Scott W Menzies; Alexandra Harbauer; Hubert Pehamberger; Klaus Wolff; Michael Binder; Harald Kittler
Accuracy of computer diagnosis of melanoma: a quantitative meta-analysis.
Archives of dermatology 2003;139(3):361-7; discussion 366.
2003: Rainer Kunstfeld; Georg Wickenhauser; Uwe Michaelis; Michael Teifel; Wolfgang Umek; Kurt Naujoks; Klaus Wolff; peter petzelbauer
Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model.
The Journal of investigative dermatology 2003;120(3):476-82.
2003: Stefan Presslauer; Gabriele Hinterhuber; Karla Cauza; Reinhard Horvat; Klemens Rappersberger; Klaus Wolff; Dagmar Foedinger
RasGAP-like protein IQGAP1 is expressed by human keratinocytes and recognized by autoantibodies in association with bullous skin disease.
The Journal of investigative dermatology 2003;120(3):365-71.
2003: Graham Scott; Stuart A Osborne; Gerard Greig; Stefan Hartmann; Marie-Eve Ebelin; Pascale Burtin; Klemens Rappersberger; Michael Komar; Klaus Wolff
Pharmacokinetics of pimecrolimus, a novel nonsteroid anti-inflammatory drug, after single and multiple oral administration.
Clinical pharmacokinetics 2003;42(14):1305-14.
2002: Wolfgang Holnthoner; Manuela Pillinger; Marion Groger; Klaus Wolff; Anthony W Ashton; Chris Albanese; Peter Neumeister; Richard G Pestell; peter petzelbauer
Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells.
The Journal of biological chemistry 2002;277(48):45847-53.
2002: Karla Cauza; Andreas Grassauer; Gabriele Hinterhuber; Reinhard Horvat; Klemens Rappersberger; Klaus Wolff; Dagmar Foedinger
FcgammaRIII expression on cultured human keratinocytes and upregulation by interferon-gamma.
The Journal of investigative dermatology 2002;119(5):1074-9.
2002: Klemens Rappersberger; Michael Komar; Marie-Eve Ebelin; Graham Scott; Pascale Burtin; Gerard Greig; Jeanne Kehren; Salah-Dine Chibout; André Cordier; Wolfgang Holter; Leo Richter; Rainer Oberbauer; Anton Stuetz; Klaus Wolff
Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated.
The Journal of investigative dermatology 2002;119(4):876-87.
2002: Christine Hafner; Ursula Samwald; Stefan Wagner; Franco Felici; Elisabeth Heere-Ress; Erika Jensen-Jarolim; Klaus Wolff; Otto Scheiner; Hubert Pehamberger; Heimo Breiteneder
Selection of mimotopes of the cell surface adhesion molecule Mel-CAM from a random pVIII-28aa phage peptide library.
The Journal of investigative dermatology 2002;119(4):865-9.
2002: Gabriele Hinterhuber; Yvonne Marquardt; Elisabeth Diem; Klemens Rappersberger; Klaus Wolff; Dagmar Foedinger
Organotypic keratinocyte coculture using normal human serum: an immunomorphological study at light and electron microscopic levels.
Experimental dermatology 2002;11(5):413-20.
2002: Harald Teufelsbauer; Alexander M Prusa; Klaus Wolff; Peter Polterauer; Joseph Nanobashvili; Manfred Prager; Thomas Hölzenbein; Siegfried Thurnher; Johannes Lammer; Michael Schemper; Georg Kretschmer; Ihor Huk
Endovascular stent grafting versus open surgical operation in patients with infrarenal aortic aneurysms: a propensity score-adjusted analysis.
Circulation 2002;106(7):782-7.
2002: Markus Dawid; Hubert Pehamberger; Klaus Wolff; Michael Binder; Harald Kittler
Evaluation of the ability of patients to identify enlarging melanocytic nevi.
Archives of dermatology 2002;138(7):984-5.
2002: Robert Loewe; Wolfgang Holnthoner; Marion Gröger; Manuela Pillinger; Florian Gruber; Diana Mechtcheriakova; Erhard Hofer; Klaus Wolff; peter petzelbauer
Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B/p65 in human endothelial cells.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(9):4781-7.
2002: Elisabeth Heere-Ress; Christiane Thallinger; Trevor Lucas; Hermine Schlagbauer-Wadl; Volker Wacheck; Brett P Monia; Klaus Wolff; Hubert Pehamberger; Burkhard Jansen
Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy.
International journal of cancer. Journal international du cancer 2002;99(1):29-34.
2002: Harald Kittler; Hubert Pehamberger; Klaus Wolff; Michael Binder
Diagnostic accuracy of dermoscopy.
The lancet oncology 2002;3(3):159-65.
2002: Klaus Wolff
Treatment of cutaneous mastocytosis.
International archives of allergy and immunology 2002;127(2):156-9.
2002: Klaus Wolff
Why is epiluminescence microscopy important?
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2002;160():125-32.
2001: Robert Loewe; Manuela Pillinger; Rainer de Martin; U Mrowietz; Marion Gröger; Wolfgang Holnthoner; Klaus Wolff; W Wiegrebe; D Jirovsky; peter petzelbauer
Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
The Journal of investigative dermatology 2001;117(6):1363-8.
2001: Michael Bergmann; Ingrid Romirer; Monika Sachet; R Fleischhacker; Adolfo García-Sastre; Peter Palese; Klaus Wolff; Hubert Pehamberger; Raimund Jakesz; Thomas Muster
A genetically engineered influenza A virus with ras-dependent oncolytic properties.
Cancer research 2001;61(22):8188-93.
2001: Robert Strohal; R Mosser; Harald Kittler; Klaus Wolff; Burkhard Jansen; Christine Brna; Georg Stingl; Hubert Pehamberger
MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression.
Melanoma research 2001;11(5):543-8.
2001: Christoph Hoeller; Burkhard Jansen; Elisabeth Heere-Ress; T Pustelnik; Ulrike Mossbacher; Hermine Schlagbauer-Wadl; Klaus Wolff; Hubert Pehamberger
Perilesional injection of r-GM-CSF in patients with cutaneous melanoma metastases.
The Journal of investigative dermatology 2001;117(2):371-4.
2001: Harald Kittler; R Weitzdorfer; Hubert Pehamberger; Klaus Wolff; Michael Binder
Compliance with follow-up and prognosis among patients with thin melanomas.
European journal of cancer (Oxford, England : 1990) 2001;37(12):1504-9.
2001: K Güven; Harald Kittler; Klaus Wolff; Hubert Pehamberger
Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients.
Melanoma research 2001;11(4):411-5.
2001: Dieter Fink; Hermine Schlagbauer-Wadl; Edgar Selzer; Trevor Lucas; Klaus Wolff; Hubert Pehamberger; Hans-Georg Eichler; Burkhard Jansen
Elevated procaspase levels in human melanoma.
Melanoma research 2001;11(4):385-93.
2001: Trevor Lucas; Barbara Pratscher; S Krishnan; Dieter Fink; Patrick Günsberg; Markus F Wolschek; Volker Wacheck; Thomas Muster; Ingrid Romirer; Klaus Wolff; Hubert Pehamberger; Hans-Georg Eichler; V M Rangnekar; Burkhard Jansen
Differential expression levels of Par-4 in melanoma.
Melanoma research 2001;11(4):379-83.
2001: Peter Valent; Hans-Peter Horny; Luis Escribano; B Jack Longley; C Y Li; Lawrence B Schwartz; G Marone; R Nuñez; Cem Akin; Karl Sotlar; Wolfgang R Sperr; Klaus Wolff; Richard D Brunning; Reza Parwaresch; K F Austen; K Lennert; Dean D Metcalfe; James W Vardiman; John M Bennett
Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Leukemia research 2001;25(7):603-25.
2001: Klaus Wolff; Michael Komar; peter petzelbauer
Clinical and histopathological aspects of cutaneous mastocytosis.
Leukemia research 2001;25(7):519-28.
2001: John-Hendrik Jordan; S Walchshofer; Wolfgang Jurecka; Isabella Mosberger; Wolfgang R Sperr; Klaus Wolff; Andreas Chott; Hans-Jörg Bühring; Klaus Lechner; Hans-Peter Horny; Peter Valent
Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Human pathology 2001;32(5):545-52.
2001: Harald Kittler; Michael Binder; Klaus Wolff; Hubert Pehamberger
A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).
Wiener klinische Wochenschrift 2001;113(9):321-7.
2001: T Halama; Marion Gröger; Manuela Pillinger; Günther Staffler; Elisabeth Prager; Hannes Stockinger; Wolfgang Holnthoner; S Lechleitner; Klaus Wolff; peter petzelbauer
Platelet endothelial cell adhesion molecule-1 and vascular endothelial cadherin cooperatively regulate fibroblast growth factor-induced modulations of adherens junction functions.
The Journal of investigative dermatology 2001;116(1):110-7.
2000: Michael Binder; Harald Kittler; Stephan Dreiseitl; H Ganster; Klaus Wolff; Hubert Pehamberger
Computer-aided epiluminescence microscopy of pigmented skin lesions: the value of clinical data for the classification process.
Melanoma research 2000;10(6):556-61.
2000: Gerit-Holger Schernthaner; E Spanblöchl; Wolfgang R Sperr; Christian Sillaber; Hans Semper; Wolfgang Jurecka; W Hagen; Klaus Wolff; Andreas Chott; Klaus Lechner; Peter Valent
Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis.
Annals of hematology 2000;79(12):660-6.
2000: Burkhard Jansen; Volker Wacheck; Elisabeth Heere-Ress; Hermine Schlagbauer-Wadl; Christoph Hoeller; Trevor Lucas; M Hoermann; Ursula Hollenstein; Klaus Wolff; Hubert Pehamberger
Chemosensitisation of malignant melanoma by BCL2 antisense therapy.
Lancet 2000;356(9243):1728-33.
2000: Marion Gröger; Wolfgang Holnthoner; Dieter Maurer; S Lechleitner; Klaus Wolff; Burkhard Mayr; Werner Lubitz; peter petzelbauer
Dermal microvascular endothelial cells express the 180-kDa macrophage mannose receptor in situ and in vitro.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(10):5428-34.
2000: Harald Kittler; Hubert Pehamberger; Klaus Wolff; Michael Binder
Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
Journal of the American Academy of Dermatology 2000;43(3):467-76.
2000: Julius Halaschek-Wiener; Volker Wacheck; Hermine Schlagbauer-Wadl; Klaus Wolff; Yoel Kloog; Burkhard Jansen
A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells.
Molecular medicine (Cambridge, Mass.) 2000;6(8):693-704.
2000: Wolfgang R Sperr; Susanne Natter; Mehrdad Baghestanian; Josef Smolen; Klaus Wolff; Bernd R Binder; Martin R Müller; Klaus Lechner; Rudolf Valenta; Peter Valent
Autoantibody reactivity in a case of Schnitzler's syndrome: evidence for a Th1-like response and detection of IgG2 anti-FcepsilonRIalpha antibodies.
International archives of allergy and immunology 2000;122(4):279-86.
2000: Michael Bergmann; Adolfo Garcia-Sastre; E Carnero; Hubert Pehamberger; Klaus Wolff; Peter Palese; Thomas Muster
Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication.
Journal of virology 2000;74(13):6203-6.
2000: Hermine Schlagbauer-Wadl; Gabriele Klosner; Elisabeth Heere-Ress; Stefan Waltering; Ingrid Moll; Klaus Wolff; Hubert Pehamberger; Burkhard Jansen
Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice.
The Journal of investigative dermatology 2000;114(4):725-30.
2000: Harald Kittler; M Seltenheim; Markus Dawid; Hubert Pehamberger; Klaus Wolff; Michael Binder
Frequency and characteristics of enlarging common melanocytic nevi.
Archives of dermatology 2000;136(3):316-20.
1999: Burkhard Jansen; Hermine Schlagbauer-Wadl; H Kahr; Elisabeth Heere-Ress; Bernhard X Mayer; H Eichler; Hubert Pehamberger; Mali Gana-Weisz; E Ben-David; Yoel Kloog; Klaus Wolff
Novel Ras antagonist blocks human melanoma growth.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(24):14019-24.
1999: Burkhard Jansen; Elisabeth Heere-Ress; Hermine Schlagbauer-Wadl; Julius Halaschek-Wiener; Stefan Waltering; Ingrid Moll; Hubert Pehamberger; Daniele Marciano; Yoel Kloog; Klaus Wolff
Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice.
Journal of molecular medicine (Berlin, Germany) 1999;77(11):792-7.
1999: T Halama; Günther Staffler; S Hoch; Hannes Stockinger; Klaus Wolff; peter petzelbauer
Vascular-endothelial cadherin (CD144)- but not PECAM-1 (CD31)-based cell-to-cell contacts convey the maintenance of a quiescent endothelial monolayer.
International archives of allergy and immunology 1999;120(3):237-44.
1999: S Lechleitner; Rainer Kunstfeld; C Messeritsch-Fanta; Klaus Wolff; peter petzelbauer
Peripheral lymph node addressins are expressed on skin endothelial cells.
The Journal of investigative dermatology 1999;113(3):410-4.
1999: Marion Gröger; Gottfried F Fischer; Klaus Wolff; peter petzelbauer
Immune complexes from vasculitis patients bind to endothelial Fc receptors independent of the allelic polymorphism of FcgammaRIIa.
The Journal of investigative dermatology 1999;113(1):56-60.
1999: Hermine Schlagbauer-Wadl; Burkhard Jansen; M Müller; P Polterauer; Klaus Wolff; Hans-Georg Eichler; Hubert Pehamberger; E Konak; J P Johnson
Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.
International journal of cancer. Journal international du cancer 1999;81(6):951-5.
1999: S Schreiber; E Kämpgen; Ernst Wagner; D Pirkhammer; J Trcka; H Korschan; A Lindemann; Roland Dorffner; Harald Kittler; F Kasteliz; Z Küpcü; A Sinski; Kurt Zatloukal; Michael Buschle; Walter Schmidt; Max L Birnstiel; RE Kempe; T Voigt; H A Weber; Hubert Pehamberger; Roland Mertelsmann; Eva-B Bröcker; Klaus Wolff; Georg Stingl
Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study.
Human gene therapy 1999;10(6):983-93.
1999: Peter Schnider; Michael Binder; Harald Kittler; Peter Birner; D Starkel; Klaus Wolff; Eduard Auff
A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis.
The British journal of dermatology 1999;140(4):677-80.
1999: Harald Kittler; M Seltenheim; Markus Dawid; Hubert Pehamberger; Klaus Wolff; Michael Binder
Morphologic changes of pigmented skin lesions: a useful extension of the ABCD rule for dermatoscopy.
Journal of the American Academy of Dermatology 1999;40(4):558-62.
1999: Hermine Schlagbauer-Wadl; Marieke Griffioen; A van Elsas; Peter I Schrier; T Pustelnik; Hans-Georg Eichler; Klaus Wolff; Hubert Pehamberger; Burkhard Jansen
Influence of increased c-Myc expression on the growth characteristics of human melanoma.
The Journal of investigative dermatology 1999;112(3):332-6.
1999: M Binder; Harald Kittler; Hubert Pehamberger; Klaus Wolff
Possible hazard to patients from immersion oil used for epiluminescence microscopy.
Journal of the American Academy of Dermatology 1999;40(3):499.
1999: Michael Binder; Harald Kittler; Andreas Steiner; Markus Dawid; Hubert Pehamberger; Klaus Wolff
Reevaluation of the ABCD rule for epiluminescence microscopy.
Journal of the American Academy of Dermatology 1999;40(2 Pt 1):171-6.
1999: I Okamoto; Hendrati Pirc-Danoewinata; Jutta Ackermann; Johannes Drach; Hermine Schlagbauer-Wadl; Burkhard Jansen; Klaus Wolff; Hubert Pehamberger; Christine Marosi
Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization.
British journal of cancer 1999;79(1):131-7.
1999: Marion Gröger; T Matsumura; Norbert Kohrgruber; Dieter Maurer; Klaus Wolff; peter petzelbauer
A standardized, a computer-assisted in vitro assay for the assessment of neutrophil transmigration across endothelial monolayers.
Journal of immunological methods 1999;222(1-2):101-9.
1998: Arno Seeber; Michael Binder; Andreas Steiner; Klaus Wolff; Hubert Pehamberger
Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine.
European journal of cancer (Oxford, England : 1990) 1998;34(13):2129-31.
1998: Rainer Kunstfeld; S Lechleitner; Klaus Wolff; peter petzelbauer
MCP-1 and MIP-1alpha are most efficient in recruiting T cells into the skin in vivo.
The Journal of investigative dermatology 1998;111(6):1040-4.
1998: Michael Binder; Andreas Steiner; Ulrike Mossbacher; M Hunegnaw; Hubert Pehamberger; Klaus Wolff
Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.
The American Journal of dermatopathology 1998;20(5):453-8.
1998: Dagmar Foedinger; Adelheid Elbe-Bürger; Barbara Sterniczky; M Lackner; Reinhard Horvat; Klaus Wolff; Klemens Rappersberger
Erythema multiforme associated human autoantibodies against desmoplakin I and II: biochemical characterization and passive transfer studies into newborn mice.
The Journal of investigative dermatology 1998;111(3):503-10.
1998: Michael Binder; Harald Kittler; Arno Seeber; Andreas Steiner; Hubert Pehamberger; Klaus Wolff
Epiluminescence microscopy-based classification of pigmented skin lesions using computerized image analysis and an artificial neural network.
Melanoma research 1998;8(3):261-6.
1998: Harald Kittler; M Seltenheim; Hubert Pehamberger; Klaus Wolff; Michael Binder
Diagnostic informativeness of compressed digital epiluminescence microscopy images of pigmented skin lesions compared with photographs.
Melanoma research 1998;8(3):255-60.
1998: Hubert Pehamberger; Hans Peter Soyer; Andreas Steiner; R Kofler; M Binder; Paul Mischer; Wolf Pachinger; J Auböck; Peter Fritsch; H Kerl; Klaus Wolff
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1425-9.
1998: I Ure; B Partsch; Klaus Wolff; peter petzelbauer
Granulocyte/macrophage colony-stimulating factor increases wound-fluid interleukin 8 in normal subjects but does not accelerate wound healing.
The British journal of dermatology 1998;138(2):277-82.
1998: Burkhard Jansen; Hermine Schlagbauer-Wadl; B D Brown; R N Bryan; A van Elsas; Markus Müller; Klaus Wolff; Hans-Georg Eichler; Hubert Pehamberger
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice.
Nature medicine 1998;4(2):232-4.
1998: B Sauter; Dagmar Foedinger; Barbara Sterniczky; Klaus Wolff; Klemens Rappersberger
Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1998;46(2):165-76.
1997: Friedrich Breier; S Fang-Kircher; Klaus Wolff; Wolfgang Jurecka
Juvenile hyaline fibromatosis: impaired collagen metabolism in human skin fibroblasts.
Archives of disease in childhood 1997;77(5):436-40.
1997: Michael Binder; Harald Kittler; Andreas Steiner; Roland Dorffner; Klaus Wolff; Hubert Pehamberger
Lymph node sonography versus palpation for detecting recurrent disease in patients with malignant melanoma.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1805-8.
1997: Margot Püspök-Schwarz; Andreas Steiner; Michael Binder; B Partsch; Klaus Wolff; Hubert Pehamberger
Statistical evaluation of epiluminescence microscopy criteria in the differential diagnosis of malignant melanoma and pigmented basal cell carcinoma.
Melanoma research 1997;7(4):307-11.
1997: Michael Binder; Andreas Steiner; Ulrike Mossbacher; M Hunegnaw; Klaus Wolff; Hubert Pehamberger
Quantification of vascularity in nodular melanoma and Spitz's nevus.
Journal of cutaneous pathology 1997;24(5):272-7.
1997: Georg Stingl; Eva-B Bröcker; Roland Mertelsmann; Klaus Wolff; S Schreiber; E Kämpgen; Achim Schneeberger; J Trcka; U Brennscheidt; Hendrik Veelken; Max L Birnstiel; Kurt Zatloukal; G Maass; Ernst Wagner; Michael Buschle; E R Kempe; H A Weber; T Voigt
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
Journal of molecular medicine (Berlin, Germany) 1997;75(4):297-9.
1997: T Matsumura; Klaus Wolff; peter petzelbauer
Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(7):3408-16.
1997: Rainer Kunstfeld; S Lechleitner; Marion Gröger; Klaus Wolff; peter petzelbauer
HECA-452+ T cells migrate through superficial vascular plexus but not through deep vascular plexus endothelium.
The Journal of investigative dermatology 1997;108(3):343-8.
1997: Michael Binder; M Puespoeck-Schwarz; Andreas Steiner; Harald Kittler; M Muellner; Klaus Wolff; Hubert Pehamberger
Epiluminescence microscopy of small pigmented skin lesions: short-term formal training improves the diagnostic performance of dermatologists.
Journal of the American Academy of Dermatology 1997;36(2 Pt 1):197-202.
1997: Burkhard Jansen; Hermine Schlagbauer-Wadl; Hans-Georg Eichler; Klaus Wolff; A van Elsas; Peter I Schrier; Hubert Pehamberger
Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis.
Cancer research 1997;57(3):362-5.
1996: peter petzelbauer; Marion Gröger; Rainer Kunstfeld; E Petzelbauer; Klaus Wolff
Human delayed-type hypersensitivity reaction in a SCID mouse engrafted with human T cells and autologous skin.
The Journal of investigative dermatology 1996;107(4):576-81.
1996: B Partsch; M Binder; M Püspök-Schwarz; Klaus Wolff; Hubert Pehamberger
Limitations of high frequency ultrasound in determining the invasiveness of cutaneous malignant melanoma.
Melanoma research 1996;6(5):395-8.
1996: Burkhard Jansen; S A Inoue; H Wadl; Hans-Georg Eichler; Klaus Wolff; A van Elsas; Peter I Schrier; Hubert Pehamberger
N-ras oncogene expression changes the growth characteristics of human melanoma in two independent SCID-hu mouse models.
International journal of cancer. Journal international du cancer 1996;67(6):821-5.
1996: L Hegemann; Guy F Webster; Klaus Wolff
Selective calmodulin antagonists fail to inhibit phorbol ester-induced superoxide anion release from human neutrophils: effects of antifungal azole derivatives.
The British journal of dermatology 1996;135(2):199-203.
1996: Dagmar Foedinger; B Sterniczky; A Elbe; Grant J Anhalt; Klaus Wolff; Klemens Rappersberger
Autoantibodies against desmoplakin I and II define a subset of patients with erythema multiforme major.
The Journal of investigative dermatology 1996;106(5):1012-6.
1996: Klemens Rappersberger; Josef G Meingassner; R Fialla; D Födinger; B Sterniczky; S Rauch; E Putz; A Stütz; Klaus Wolff
Clearing of psoriasis by a novel immunosuppressive macrolide.
The Journal of investigative dermatology 1996;106(4):701-10.
1996: Georg Stingl; E B Brŏcker; Roland Mertelsmann; Klaus Wolff; S Schreiber; E Kămpgen; Achim Schneeberger; W Dummer; U Brennscheid; Hendrik Veelken; Max L Birnstiel; Kurt Zatloukal; Walter Schmidt; G Maass; Ernst Wagner; M Baschle; M Giese; E R Kempe; H A Weber; T Voigt
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
Human gene therapy 1996;7(4):551-63.
1996: Ulrike Mossbacher; S Knollmayer; M Binder; Andreas Steiner; Klaus Wolff; Hubert Pehamberger
Increased nuclear volume in metastasizing "thick" melanomas.
The Journal of investigative dermatology 1996;106(3):437-40.
1996: Marion Gröger; G Sarmay; Edda Fiebiger; Klaus Wolff; peter petzelbauer
Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(4):1549-56.
1995: L Hegemann; C Forstinger; B Partsch; I Lagler; S Krotz; Klaus Wolff
Microdialysis in cutaneous pharmacology: kinetic analysis of transdermally delivered nicotine.
The Journal of investigative dermatology 1995;104(5):839-43.
1995: M Binder; M Schwarz; A Winkler; Andreas Steiner; A Kaider; Klaus Wolff; Hubert Pehamberger
Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists.
Archives of dermatology 1995;131(3):286-91.
1995: Dagmar Foedinger; Grant J Anhalt; B Boecskoer; A Elbe; Klaus Wolff; Klemens Rappersberger
Autoantibodies to desmoplakin I and II in patients with erythema multiforme.
The Journal of experimental medicine 1995;181(1):169-79.
1994: M Binder; Andreas Steiner; M Schwarz; S Knollmayer; Klaus Wolff; Hubert Pehamberger
Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study.
The British journal of dermatology 1994;130(4):460-5.
1994: Andreas Steiner; M Binder; Ulrike Mossbacher; Klaus Wolff; Hubert Pehamberger
Estimation of the volume-weighted mean nuclear volume discriminates Spitz's nevi from nodular malignant melanomas.
Laboratory investigation; a journal of technical methods and pathology 1994;70(3):381-5.
1994: Klaus Wolff; M Binder; Hubert Pehamberger
Epiluminescence microscopy: a new approach to the early detection of melanoma.
Advances in dermatology 1994;9():45-56; discussion 57.
1993: Andreas Steiner; M Binder; M Schemper; Klaus Wolff; Hubert Pehamberger
Statistical evaluation of epiluminescence microscopy criteria for melanocytic pigmented skin lesions.
Journal of the American Academy of Dermatology 1993;29(4):581-8.
1993: peter petzelbauer; D Födinger; Klemens Rappersberger; Beatrix Volc-Platzer; Klaus Wolff
CD68 positive epidermal dendritic cells.
The Journal of investigative dermatology 1993;101(3):256-61.
1993: Robert Strohal; Klemens Rappersberger; Hubert Pehamberger; Klaus Wolff
Nonbullous pemphigoid: prodrome of bullous pemphigoid or a distinct pemphigoid variant?
Journal of the American Academy of Dermatology 1993;29(2 Pt 2):293-9.
1993: Hubert Pehamberger; M Binder; Andreas Steiner; Klaus Wolff
Early recognition and prognostic markers of melanoma.
Melanoma research 1993;3(4):279-84.
1993: Hubert Pehamberger; M Binder; S Knollmayer; Klaus Wolff
Immediate effects of a public education campaign on prognostic features of melanoma.
Journal of the American Academy of Dermatology 1993;29(1):106-9.
1993: Hubert Pehamberger; M Binder; Andreas Steiner; Klaus Wolff
In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma.
The Journal of investigative dermatology 1993;100(3):356S-362S.
1992: Andreas Steiner; Hubert Pehamberger; M Binder; Klaus Wolff
Pigmented Spitz nevi: improvement of the diagnostic accuracy by epiluminescence microscopy.
Journal of the American Academy of Dermatology 1992;27(5 Pt 1):697-701.
1992: R Berger; Suzanne Gartner; Klemens Rappersberger; C A Foster; Klaus Wolff; Georg Stingl
Isolation of human immunodeficiency virus type 1 from human epidermis: virus replication and transmission studies.
The Journal of investigative dermatology 1992;99(3):271-7.
1992: M Binder; I Dolezal; Klaus Wolff; Hubert Pehamberger
Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma.
The Journal of investigative dermatology 1992;99(2):180-3.
1992: M J Mihatsch; Klaus Wolff
Consensus conference on cyclosporin A for psoriasis February 1992.
The British journal of dermatology 1992;126(6):621-3.
1992: peter petzelbauer; Klaus Wolff; G Tappeiner
Necrobiosis lipoidica: treatment with systemic corticosteroids.
The British journal of dermatology 1992;126(6):542-5.
1992: M Binder; A Winkler; Roland Dorffner; E Glebowski; Klaus Wolff; Hubert Pehamberger
Fotemustine plus dacarbazine in advanced stage III malignant melanoma.
European journal of cancer (Oxford, England : 1990) 1992;28A(11):1814-6.
1991: R Gillitzer; R Berger; V Mielke; C Müller; Klaus Wolff; Georg Stingl
Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ.
The Journal of investigative dermatology 1991;97(1):73-9.
1991: Beatrix Volc-Platzer; Peter Valent; T Radaszkiewicz; P Mayer; P Bettelheim; Klaus Wolff
Recombinant human interleukin 3 induces proliferation of inflammatory cells and keratinocytes in vivo.
Laboratory investigation; a journal of technical methods and pathology 1991;64(4):557-66.
1991: peter petzelbauer; Georg Stingl; Klaus Wolff; Beatrix Volc-Platzer
Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques.
The Journal of investigative dermatology 1991;96(3):362-9.
1990: peter petzelbauer; Herbert Hönigsmann; K Langer; B Anegg; Robert Strohal; Adrian Tanew; Klaus Wolff
Cyclosporin A in combination with photochemotherapy (PUVA) in the treatment of psoriasis.
The British journal of dermatology 1990;123(5):641-7.
1990: M Honjo; A Elbe; G Steiner; I Assmann; Klaus Wolff; Georg Stingl
Thymus-independent generation of Thy-1+ epidermal cells from a pool of Thy-1- bone marrow precursors.
The Journal of investigative dermatology 1990;95(5):562-7.
1990: Beatrix Volc-Platzer; Herbert Hönigsmann; W Hinterberger; Klaus Wolff
Photochemotherapy improves chronic cutaneous graft-versus-host disease.
Journal of the American Academy of Dermatology 1990;23(2 Pt 1):220-8.
1990: Klaus Wolff
Side-effects of psoralen photochemotherapy (PUVA).
The British journal of dermatology 1990;122 Suppl 36():117-25.
1990: Georg Stingl; Klemens Rappersberger; Erwin Tschachler; Suzanne Gartner; Veronika Groh; Dean L Mann; Klaus Wolff; M Popovic
Langerhans cells in HIV-1 infection.
Journal of the American Academy of Dermatology 1990;22(6 Pt 2):1210-7.
1990: K Langer; K Konrad; Klaus Wolff
Keratitis, ichthyosis and deafness (KID)-syndrome: report of three cases and a review of the literature.
The British journal of dermatology 1990;122(5):689-97.
1990: Klemens Rappersberger; M Binder; E Zonzits; U Hornick; Klaus Wolff
Immunogold staining of intermediate-sized filaments of the vimentin type in human skin: a postembedding immunoelectron microscopic study.
The Journal of investigative dermatology 1990;94(5):700-5.
1990: C A Foster; H Yokozeki; Klemens Rappersberger; F Koning; Beatrix Volc-Platzer; A Rieger; John E Coligan; Klaus Wolff; Georg Stingl
Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor.
The Journal of experimental medicine 1990;171(4):997-1013.
1990: H Wilfert; Herbert Hönigsmann; Günter Steiner; Josef Smolen; Klaus Wolff
Treatment of psoriatic arthritis by extracorporeal photochemotherapy.
The British journal of dermatology 1990;122(2):225-32.
1990: K Langer; Klemens Rappersberger; Andreas Steiner; K Konrad; Klaus Wolff
The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi.
Archives of dermatological research 1990;282(6):353-62.
1990: M Binder; Hubert Pehamberger; Andreas Steiner; Klaus Wolff
Elective regional lymph node dissection in malignant melanoma.
European journal of cancer (Oxford, England : 1990) 1990;26(8):871-3.
1989: A Elbe; Erwin Tschachler; G Steiner; A Binder; Klaus Wolff; Georg Stingl
Maturational steps of bone marrow-derived dendritic murine epidermal cells. Phenotypic and functional studies on Langerhans cells and Thy-1+ dendritic epidermal cells in the perinatal period.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(8):2431-8.
1989: Klemens Rappersberger; Erwin Tschachler; M Tani; Klaus Wolff
Bullous disease in systemic lupus erythematosus.
Journal of the American Academy of Dermatology 1989;21(4 Pt 1):745-52.
1989: Klemens Rappersberger; Herbert Hönigsmann; B Ortel; Adrian Tanew; K Konrad; Klaus Wolff
Photosensitivity and hyperpigmentation in amiodarone-treated patients: incidence, time course, and recovery.
The Journal of investigative dermatology 1989;93(2):201-9.
1989: Erwin Tschachler; G Steiner; H Yamada; A Elbe; Klaus Wolff; Georg Stingl
Dendritic epidermal T cells: activation requirements and phenotypic characterization of proliferating cells.
The Journal of investigative dermatology 1989;92(5):763-8.
1989: Karl Holubar; Klaus Wolff
The genesis of American investigative dermatology from its roots in Europe.
The Journal of investigative dermatology 1989;92(4 Suppl):14S-21S.
1989: Herbert Hönigsmann; Klaus Wolff
Results of therapy for psoriasis using retinoid and photochemotherapy (RePUVA).
Pharmacology & therapeutics 1989;40(1):67-73.
1989: C Wolf; Hubert Pehamberger; S Breyer; K M Leiferman; Klaus Wolff
Episodic angioedema with eosinophilia.
Journal of the American Academy of Dermatology 1989;20(1):21-7.
1989: Georg Stingl; Erwin Tschachler; Veronika Groh; Klaus Wolff; C Hauser
The immune functions of epidermal cells.
Immunology series 1989;46():3-72.
1988: Andreas Steiner; K Konrad; Hubert Pehamberger; Klaus Wolff
Verrucous malignant melanoma.
Archives of dermatology 1988;124(10):1534-7.
1988: Beatrix Volc-Platzer; Klemens Rappersberger; Isabella Mosberger; Wolfgang Hinterberger; W Emminger-Schmidmeier; T Radaszkiewicz; Klaus Wolff
Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation.
The Journal of investigative dermatology 1988;91(2):162-8.
1988: Beatrix Volc-Platzer; Andreas Steiner; T Radaszkiewicz; Klaus Wolff
Recombinant gamma interferon and in vivo induction of HLA-DR antigens.
The British journal of dermatology 1988;119(2):155-60.
1988: Veronika Groh; Helmut Gadner; T Radaszkiewicz; Klemens Rappersberger; K Konrad; Klaus Wolff; Georg Stingl
The phenotypic spectrum of histiocytosis X cells.
The Journal of investigative dermatology 1988;90(4):441-7.
1988: W Aberer; K Konrad; Klaus Wolff
Wells' syndrome is a distinctive disease entity and not a histologic diagnosis.
Journal of the American Academy of Dermatology 1988;18(1 Pt 1):105-14.
1988: Klemens Rappersberger; Suzanne Gartner; Peter Schenk; Georg Stingl; Veronika Groh; Erwin Tschachler; Dean L Mann; Klaus Wolff; K Konrad; M Popovic
Langerhans' cells are an actual site of HIV-1 replication.
Intervirology 1988;29(4):185-94.
1987: Karl Holubar; Klaus Wolff
Kaposi sesquicentennial, Oct. 23, 1987.
Journal of the American Academy of Dermatology 1987;17(6):1082-4.
1987: Andreas Steiner; Hubert Pehamberger; Klaus Wolff
In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma.
Journal of the American Academy of Dermatology 1987;17(4):584-91.
1987: Hubert Pehamberger; Andreas Steiner; Klaus Wolff
In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions.
Journal of the American Academy of Dermatology 1987;17(4):571-83.
1987: Klaus Wolff; Klemens Rappersberger; Andreas Steiner; K Konrad
Vegetating cicatricial pemphigoid. A new subset of the cicatricial pemphigoid spectrum.
Archives of dermatological research 1987;279 Suppl():S30-7.
1987: Georg Stingl; N Romani; Klaus Wolff
Langerhans' cells: a distinctive member of bone marrow-derived dendritic cells.
Advances in dermatology 1987;2():269-81.
1985: H Leibl; Georg Stingl; Hubert Pehamberger; H Korschan; K Konrad; Klaus Wolff
Inhibition of DNA synthesis of melanoma cells by azelaic acid.
The Journal of investigative dermatology 1985;85(5):417-22.
1985: H Leibl; J Hutterer; H Korschan; Gerold Schuler; M Tani; E Tschachler; N Romani; Klaus Wolff; Georg Stingl
Expression of the Ly-5 alloantigenic system on epidermal cells.
The Journal of investigative dermatology 1985;84(2):91-5.
1983: E Tschachler; G Schuler; J Hutterer; H Leibl; Klaus Wolff; Georg Stingl
Expression of Thy-1 antigen by murine epidermal cells.
The Journal of investigative dermatology 1983;81(3):282-5.
1983: Klaus Wolff; Georg Stingl
The langerhans cell.
The Journal of investigative dermatology 1983;80(1 Suppl):17s-21s.